KEVIN FISHER to Immunohistochemistry
This is a "connection" page, showing publications KEVIN FISHER has written about Immunohistochemistry.
Connection Strength
0.227
-
Immunohistochemical Investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies. Appl Immunohistochem Mol Morphol. 2014 Sep; 22(8):562-7.
Score: 0.054
-
Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Hum Pathol. 2014 Nov; 45(11):2281-93.
Score: 0.054
-
Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma. J Surg Res. 2013 Nov; 185(1):217-24.
Score: 0.050
-
The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis. Hematol Oncol. 2018 Feb; 36(1):307-315.
Score: 0.016
-
The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer. Appl Immunohistochem Mol Morphol. 2015 Apr; 23(4):239-44.
Score: 0.014
-
BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression. Appl Immunohistochem Mol Morphol. 2014 Oct; 22(9):648-51.
Score: 0.014
-
HER2 in resected gastric cancer: Is there prognostic value? J Surg Oncol. 2014 Feb; 109(2):61-6.
Score: 0.013
-
Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma. Cancer. 2013 Sep 01; 119(17):3242-50.
Score: 0.012